More Globe Newswire

View Older Stories View Newer Stories

Nov 6, 2025 08:30AM zSpace Expands Global Footprint with AI-Powered Inspire 2 AR/VR Laptop Launch at GESS Dubai 2025
Nov 6, 2025 08:30AM PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"
Nov 6, 2025 08:28AM Orion to Participate in Craig-Hallum Alpha Select Conference on November 18, 2025
Nov 6, 2025 08:23AM EXL named a Leader in Everest Group Property and Casualty (P&C) Insurance BPS PEAK Matrix® Assessment 2025
Nov 6, 2025 08:23AM EXL named a Leader in Everest Group Property and Casualty (P&C) Insurance BPS PEAK Matrix® Assessment 2025
Nov 6, 2025 08:20AM Mobilicom to Report Third Quarter 2025 Financial and Operational Results
Nov 6, 2025 08:19AM Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand
Nov 6, 2025 08:15AM Skyline Announces Change in Strategy, New Management and First Acquisition in Critical Minerals Space
Nov 6, 2025 08:15AM Greystone Housing Impact Investors Reports Third Quarter 2025 Financial Results and Operational Initiatives
Nov 6, 2025 08:15AM Mustang’s Moses made Week 10 Lott IMPACT Trophy Player of the Week
Nov 6, 2025 08:10AM Studio City International Holdings Limited Announces Unaudited Third Quarter 2025 Earnings
Nov 6, 2025 08:09AM A&K Robotics Welcomes Melonee Wise to Board of Advisors
Nov 6, 2025 08:09AM A&K Robotics Welcomes Melonee Wise to Board of Advisors
Nov 6, 2025 08:06AM Duos Edge AI Joins Nomad Futurist Foundation as Inspiration Sponsor
Nov 6, 2025 08:06AM RentRedi Recognized as a 2025 Inc. Power Partner Award Winner for Third Consecutive Year
Nov 6, 2025 08:05AM NAPC Defense Launches Grant Initiative to Equip School Resource Officers Nationwide with CornerShot Tactical Systems
Nov 6, 2025 08:05AM The Metals Company Announces Third Quarter 2025 Corporate Update Conference Call for Thursday, November 13, 2025
Nov 6, 2025 08:05AM IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025
Nov 6, 2025 08:05AM Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
Nov 6, 2025 08:00AM Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
Nov 6, 2025 08:00AM Skyharbour’s Partner Mustang Energy Corp. Announces Results of TDEM Survey Over the 914W Property
Nov 6, 2025 08:01AM Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
Nov 6, 2025 08:00AM Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2025 08:00AM Journal of the American Academy of Special Education Professionals (JAASEP), a publication of the National Association of Special Education Teachers (NASET), announces new editorial leadership and the
Nov 6, 2025 08:00AM Greenridge Exploration Highlights Successful Results of Airborne Electromagnetic and Radiometric Survey for the Flying Vee Project
Nov 6, 2025 08:00AM 8MBets Online Casino Nepal Celebrates Successful 1st Year and Aims to Become the Best Online Casino in Nepal
Nov 6, 2025 08:00AM Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 6, 2025 08:00AM VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Nov 6, 2025 08:00AM Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
Nov 6, 2025 08:01AM QieDex Unveils Decentralized Trading and Token Creation Platform on the Lightning-Fast QIE Network
Nov 6, 2025 08:02AM Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
Nov 6, 2025 08:02AM Cytrellis Secures FDA Clearance for Full Body Resurfacing Using Ellacor® Micro-Coring® Technology
Nov 6, 2025 08:00AM Timeless Builds: Specialist Pool and Backyard Remodeling Company Announces Immersive New Website
Nov 6, 2025 08:00AM Celldex Presents Results from Barzolvolimab Phase 2 Study in Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Demonstrating Sustained Efficacy and Favorable Safety Profile over 20 Week Placeb
Nov 6, 2025 08:00AM Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
Nov 6, 2025 08:00AM Imbria Pharmaceuticals Announces First Patient Randomized in FORTITUDE-HCM Phase 2b Clinical Trial Evaluating Ninerafaxstat for Non-Obstructive Hypertrophic Cardiomyopathy
Nov 6, 2025 08:00AM For the Second Consecutive Year, Provident Bank Announces $50,000 in Grants to 6 Non-Profit Organizations
Nov 6, 2025 08:00AM Aemetis Reports Third Quarter 2025 Financial Results
Nov 6, 2025 08:00AM Feed a Family of 10 for Under $40 this Thanksgiving: Stop & Shop Introduces One of the Season’s Best Dinner Deals
Nov 6, 2025 08:00AM *MEDIA ALERT* Verizon and David Beckham Launch First-Ever "Golden Ticket" Sweepstakes for FIFA World Cup 26™
Nov 6, 2025 08:00AM Sironax Announces Three Abstracts Selected for Presentation at Neuroscience 2025
Nov 6, 2025 08:00AM Evotrex Exits Stealth with $16 Million Pre-A to Debut the World’s First Power-Generating RV Trailer at CES 2026
Nov 6, 2025 08:00AM Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015
Nov 6, 2025 08:00AM Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
Nov 6, 2025 08:00AM Enphase Energy IQ8 Microinverters Power Solar Projects at Gas Stations Worldwide
Nov 6, 2025 08:00AM Zscaler to Host First Quarter Fiscal Year 2026 Earnings Conference Call
Nov 6, 2025 08:00AM STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansio
Nov 6, 2025 08:00AM HPQ CEO Applauds and Comments on Canada’s New Federal Budget and Its Positive Impact on HPQ’s Technology Portfolio
Nov 6, 2025 08:00AM Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study
Nov 6, 2025 08:00AM LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates
View Newer Stories View Older Stories